Pregnancy and injecting drug use.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18535073.
- Also identified by DOI 10.1136/bmj.39514.554375.AE and PMC identifier 2413389.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Injecting drug use has adverse effects on pregnancy and perinatal outcomes. Methadone treatment improves birth rate but carries a risk of neonatal abstinence syndrome; withdrawal of methadone during pregnancy is not recommended
Medical subject headings
- Opioid-Related Disorders
- Pregnancy Complications
- Substance Abuse, Intravenous